Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Adore Beauty Group (ABY.AX)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2020-11-206.69-No Rating
2020-12-075.766.20Neutral
2021-02-235.496.20Buy
2021-05-063.705.60Buy
2021-08-304.976.00Buy
2022-02-162.474.70Buy
2022-04-281.693.40Buy
2022-06-161.052.10Buy
2022-10-271.562.00Buy
2022-11-181.761.95Neutral
2023-02-271.031.25Neutral
2023-05-010.961.15Neutral
2023-08-231.051.25Neutral
2023-10-301.001.15Neutral

Disclosures

  • UBS Securities Australia Limited is acting as takeover response adviser to Adore Beauty Group, and may receive a fee for acting in this capacity.
  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.